EPISODE · Dec 3, 2020 · 1 MIN
Andreas Hochhaus, MD, Talks About the ASCEMBL Trial, Eliminating LSCs in CML
from Oncology Learning Network · host HMP Global
In this podcast, Andreas Hochhaus, MD, University Medical Center Jena, Germany, discusses the significance of the ASCEMBL trial presented at the virtual 2020 ASH Annual Meeting and Exposition, and proposes the question of how to eliminate persisting leukemic stem cells (LSCs) in chronic myeloid leukemia (CML).
Embed this episode
Ready to play
Andreas Hochhaus, MD, Talks About the ASCEMBL Trial, Eliminating LSCs in CML
0:00
1:47
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Learning Network?
This episode is 1 minute long.
When was this Oncology Learning Network episode published?
This episode was published on December 3, 2020.
Can I download this Oncology Learning Network episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!